In human cancers, tandem duplication phenotypes of this same size distribution are thought to be driven by the loss of TP53 and BRCA1 (ref. 42), indicating that a parallel mutational process may be influencing the observed genome instability in MarBTN and more active in the USA sub-lineage. This evidence concerns the gene BRCA1 and cancer.